BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 36506323)

  • 1. Genes in pediatric pulmonary arterial hypertension and the most promising
    Dai L; Du L
    Front Genet; 2022; 13():961848. PubMed ID: 36506323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetic framework underlying pulmonary arterial hypertension.
    Southgate L; Machado RD; Gräf S; Morrell NW
    Nat Rev Cardiol; 2020 Feb; 17(2):85-95. PubMed ID: 31406341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genes that drive the pathobiology of pediatric pulmonary arterial hypertension.
    Welch CL; Austin ED; Chung WK
    Pediatr Pulmonol; 2021 Mar; 56(3):614-620. PubMed ID: 31917901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.
    Zhu N; Swietlik EM; Welch CL; Pauciulo MW; Hagen JJ; Zhou X; Guo Y; Karten J; Pandya D; Tilly T; Lutz KA; Martin JM; Treacy CM; Rosenzweig EB; Krishnan U; Coleman AW; Gonzaga-Jauregui C; Lawrie A; Trembath RC; Wilkins MR; ; ; ; ; Morrell NW; Shen Y; Gräf S; Nichols WC; Chung WK
    Genome Med; 2021 May; 13(1):80. PubMed ID: 33971972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of genetics in pulmonary arterial hypertension.
    Ma L; Chung WK
    J Pathol; 2017 Jan; 241(2):273-280. PubMed ID: 27770446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
    Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
    Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the Methylation and Expression Levels of the BMPR2 Gene by SIN3a as a Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension.
    Bisserier M; Mathiyalagan P; Zhang S; Elmastour F; Dorfmüller P; Humbert M; David G; Tarzami S; Weber T; Perros F; Sassi Y; Sahoo S; Hadri L
    Circulation; 2021 Jul; 144(1):52-73. PubMed ID: 34078089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic basis of pulmonary arterial hypertension.
    Ma L; Chung WK
    Hum Genet; 2014 May; 133(5):471-9. PubMed ID: 24442418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics and Other Omics in Pediatric Pulmonary Arterial Hypertension.
    Welch CL; Chung WK
    Chest; 2020 May; 157(5):1287-1295. PubMed ID: 32006592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
    Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
    J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Analysis of BMPR2, TBX4, and KCNK3 and Genotype-Phenotype Correlations in Spanish Patients and Families With Idiopathic and Hereditary Pulmonary Arterial Hypertension.
    Navas P; Tenorio J; Quezada CA; Barrios E; Gordo G; Arias P; López Meseguer M; Santos-Lozano A; Palomino Doza J; Lapunzina P; Escribano Subías P
    Rev Esp Cardiol (Engl Ed); 2016 Nov; 69(11):1011-1019. PubMed ID: 27453251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension.
    Bisserier M; Katz MG; Bueno-Beti C; Brojakowska A; Zhang S; Gubara S; Kohlbrenner E; Fazal S; Fargnoli A; Dorfmuller P; Humbert M; Hata A; Goukassian DA; Sassi Y; Hadri L
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMAD1 deficiency in either endothelial or smooth muscle cells can predispose mice to pulmonary hypertension.
    Han C; Hong KH; Kim YH; Kim MJ; Song C; Kim MJ; Kim SJ; Raizada MK; Oh SP
    Hypertension; 2013 May; 61(5):1044-52. PubMed ID: 23478097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of BMPR2 mutations in pulmonary arterial hypertension.
    Tatius B; Wasityastuti W; Astarini FD; Nugrahaningsih DAA
    Respir Investig; 2021 Jul; 59(4):397-407. PubMed ID: 34023242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension.
    Kerstjens-Frederikse WS; Bongers EM; Roofthooft MT; Leter EM; Douwes JM; Van Dijk A; Vonk-Noordegraaf A; Dijk-Bos KK; Hoefsloot LH; Hoendermis ES; Gille JJ; Sikkema-Raddatz B; Hofstra RM; Berger RM
    J Med Genet; 2013 Aug; 50(8):500-6. PubMed ID: 23592887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
    Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
    Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension.
    Hong KH; Lee YJ; Lee E; Park SO; Han C; Beppu H; Li E; Raizada MK; Bloch KD; Oh SP
    Circulation; 2008 Aug; 118(7):722-30. PubMed ID: 18663089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension.
    Eichstaedt CA; Saßmannshausen Z; Shaukat M; Cao D; Xanthouli P; Gall H; Sommer N; Ghofrani HA; Seyfarth HJ; Lerche M; Halank M; Kleymann J; Benjamin N; Harutyunova S; Egenlauf B; Milger K; Rosenkranz S; Ewert R; Klose H; Hoeper MM; Olsson KM; Lankeit M; Lange TJ; Hinderhofer K; Grünig E
    Respir Res; 2022 Mar; 23(1):74. PubMed ID: 35346192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.